Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib
Leukemia ( IF 12.8 ) Pub Date : 2022-07-16 , DOI: 10.1038/s41375-022-01640-y Audrey M Sigmund 1 , Ying Huang 1 , Amy S Ruppert 1 , Kami Maddocks 1 , Kerry A Rogers 1 , Samantha Jaglowski 1 , Seema A Bhat 1 , Adam S Kittai 1 , Michael R Grever 1 , John C Byrd 1, 2 , Jennifer A Woyach 1
中文翻译：
接受依鲁替尼治疗的慢性淋巴细胞白血病患者的反应深度和无进展生存期
更新日期：2022-07-16
Leukemia ( IF 12.8 ) Pub Date : 2022-07-16 , DOI: 10.1038/s41375-022-01640-y Audrey M Sigmund 1 , Ying Huang 1 , Amy S Ruppert 1 , Kami Maddocks 1 , Kerry A Rogers 1 , Samantha Jaglowski 1 , Seema A Bhat 1 , Adam S Kittai 1 , Michael R Grever 1 , John C Byrd 1, 2 , Jennifer A Woyach 1
Affiliation
|
中文翻译：
接受依鲁替尼治疗的慢性淋巴细胞白血病患者的反应深度和无进展生存期
京公网安备 11010802027423号